Tian Zhang, MD
LightNews LightNews
banner
tiansterzhangmd.bsky.social
Tian Zhang, MD
@tiansterzhangmd.bsky.social
1.5K followers 230 following 57 posts
I treat & research GU cancers @UTSW in Dallas. Columbia/Harvard Med/Duke alum; Mom & wife
Posts=my opinions
ASCO COI: https://coi.asco.org/share/3UF-6U3Z/Tian%20Zhang
Posts Replies Media Videos
Reposted by Tian Zhang, MD
oncodaily.bsky.social
Prostate Cancer Advances at ESMO25 with Tian Zhang

@tiansterzhangmd.bsky.social @myesmo.bsky.social

oncodaily.com/voices/prost...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025 #ProstateCancer
Prostate Cancer Advances at ESMO25 with Tian Zhang - OncoDaily
Prostate Cancer Advances at ESMO25 with Tian Zhang / cancer, ESMO, ESMO 2025, ESMO2025, ESMO25, Headlines, OncoDaily, Oncology
oncodaily.com
October 20, 2025 at 9:58 PM
Reposted by Tian Zhang, MD
oncodaily.bsky.social
ESMO 2025 - The Grand Catch-Up (Berlin, October 17-21, 2025)

@myesmo.bsky.social @ptarantinomd.bsky.social @erikahamilton9.bsky.social @stephenvliu.bsky.social @arndtvogel.bsky.social @tiansterzhangmd.bsky.social

oncodaily.com/blog/esmo-20...

#OncoDaily #Oncology #Cancer #ESMO #ESMO25 #ESMO2025
ESMO 2025 - The Grand Catch-Up (Berlin, October 17-21, 2025) - OncoDaily
ESMO 2025 - The Grand Catch-Up (Berlin, October 17-21, 2025) / Alberto Puccini, Amalya Sargsyan, Antonio Calles, Arndt Vogel, Arturo Loaiza-Bonilla, Berlin,
oncodaily.com
October 24, 2025 at 8:58 PM
tiansterzhangmd.bsky.social
Glad to be an #ESMOAmbassador during #ESMO25 in Berlin! Here to learn the latest data for our patients and share ideas to improve future outcomes. See you in Berlin! @oncoalert.bsky.social
myesmo.bsky.social ESMO - European Society for Medical Oncology @myesmo.bsky.social · Oct 10
#ESMO25: Do not miss the latest findings in #CancerResearch brought to you by the #ESMOAmbassadors & become part of the conversation in #oncology.
🔗 ow.ly/Tkr850X9A1a
October 17, 2025 at 3:02 PM
Reposted by Tian Zhang, MD
oncodaily.bsky.social
Great Editorial Led by Nicolas Sayegh on Subsets of Prostate Cancer - Tian Zhang
@tiansterzhangmd.bsky.social

oncodaily.com/insight/nico...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ProstateCancer
Tian Zhang: Great Editorial Led by Nicolas Sayegh on Subsets of Prostate Cancer - OncoDaily
Tian Zhang: Great Editorial Led by Nicolas Sayegh on Subsets of Prostate Cancer /
oncodaily.com
August 6, 2025 at 7:03 PM
Reposted by Tian Zhang, MD
vjoncology.bsky.social
🎥Results from PDIGREE: ipi + nivo in mccRCC shows consistent safety & early CRs in a diverse U.S. population

@tiansterzhangmd.bsky.social shares insights from #ASCO25

➡️https://buff.ly/o2oUojf⬅️

@ASCO #kcsm #UroOnc #UroSoMe #CTSM #TrialUpdate #ImmunoOnc
Ipilimumab and nivolumab induction in PDIGREE: step 1 findings in mccRCC - VJOncology
Tian Zhang, MD, UT Southwestern Medical Center, Dallas, TX, describes results from step 1 of the PDIGREE trial (NCT03793166), which...
buff.ly
July 22, 2025 at 8:02 AM
tiansterzhangmd.bsky.social
#ShahneenSandhu on collaborative efforts with industry partners - how do we maximize time & effort to make industry supported IITs and large phase 3 trials for clinical development. @anzuptrials.bsky.social #ANZUP25
July 19, 2025 at 11:45 PM
tiansterzhangmd.bsky.social
@profiand.bsky.social with key insights to large trial and grant funding in Australia — trial impact, equity in diverse populations, cost effectiveness, patient advocate/consumer involvement, and feasibility @anzuptrials.bsky.social #ANZUP25
July 19, 2025 at 11:28 PM
tiansterzhangmd.bsky.social
Great kickoff to clinical trials workshop #ANZUP25 — #MelissaLeMesurier w patient perspective and #ChrisGianacas biostats on collaborative efforts for clinical trials. Same global themes for clinical trial development. @anzuptrials.bsky.social @craiggedye.bsky.social @profiand.bsky.social
July 19, 2025 at 11:19 PM
tiansterzhangmd.bsky.social
Pleasure to highlight your work with #UroToday @ravimadan.bsky.social - as we all consider how best to treat PSMA avid disease.
July 19, 2025 at 11:17 PM
tiansterzhangmd.bsky.social
Proud of our #UTSWcancer clinical research teams displaying our cancer center’s ongoing work in clinical trials @aacicancer.bsky.social #CRI25 meeting today! Clinical trials are essential to improving outcomes for our patients with cancer - here to network & learn best practices!
June 24, 2025 at 2:46 AM
Reposted by Tian Zhang, MD
meganranney.bsky.social
I categorically refuse to accept either of these as normal or routine.

www.nytimes.com/2025/06/14/u...
Like School Shootings, Political Violence Is Becoming Almost Routine
www.nytimes.com
June 15, 2025 at 2:04 AM
tiansterzhangmd.bsky.social
See our #Urotoday recording with David Wise on this promising trial in #prostatecancer reported at #ASCO25!

urldefense.com/v3/__https:/...
June 3, 2025 at 1:37 PM
Reposted by Tian Zhang, MD
ascocancer.bsky.social
New from #ASCO25: Final results of CheckMate-214 show that nivo + ipi continues to improve OS compared with sunitinib for previously untreated advanced RCC: dailynews.ascopubs.org/do/checkmate... #ASCODailyNews @mskcancercenter.bsky.social @tiansterzhangmd.bsky.social
June 1, 2025 at 5:49 PM
tiansterzhangmd.bsky.social
Traveling w/ mixed emotions to @asco #asco25 this yr. Celebrating science & the yrs of dedication, work, & patient contributions to cancer clinical trials. But science itself is under attack — defunding of preclinical discovery work will end up slowing our clinical advances. 1/n
May 30, 2025 at 11:50 AM
tiansterzhangmd.bsky.social
Our hearts go out to the Biden family. Metastatic prostate cancer is common but hard. They will face many treatment decisions ahead. apple.news/Ai-QLq9onRNW...
Biden diagnosed with ‘aggressive form’ of prostate cancer — CNN
Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer, according to a statement from his personal office Sunday, and it has spread to his bones.
apple.news
May 19, 2025 at 3:27 AM
Reposted by Tian Zhang, MD
oncodaily.bsky.social
Women in RCC Negotiations Spotlight at IKCSEU25 - Tian Zhang
@tiansterzhangmd.bsky.social
@drnataliagandur.bsky.social
@kidney-cancer.bsky.social

oncodaily.com/blog/tian-zh...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IKCSEU25 #RCC #IKCS25 #WomenInRCC
Tian Zhang: Women in RCC Negotiations Spotlight at IKCSEU25 - OncoDaily
Tian Zhang: Women in RCC Negotiations Spotlight at IKCSEU25 / cancer, Cora Sternberg, IKCS25, IKCSEU25, Kidney Cancer Association, Laurence Albiges, Lisa
oncodaily.com
May 5, 2025 at 5:02 PM
tiansterzhangmd.bsky.social
Plenary session with @MarcelaMaus @MGHCancerCenter on future CAR-T cells — setting vision toward personalized, patient centered approaches to find the right CARTs. #AACR25 @oncoalert.bsky.social @theaacr.bsky.social
April 28, 2025 at 2:08 PM
Reposted by Tian Zhang, MD
sadlersnaps.bsky.social
Hey all my #Cansky and especially #Kidneycancer folks, check out this awesome episode from @lauraesfeller.bsky.social and Judy Nicholson Foundation featuring @tiansterzhangmd.bsky.social. Fantastic episode👏🏻👏🏻.

youtu.be/25TXzH5suio?...
Real Talk on Renal Cancer: Dr. Tian Zhang (Episode 14)
YouTube video by Judy Nicholson Kidney Cancer Foundation
youtu.be
April 22, 2025 at 2:28 AM
tiansterzhangmd.bsky.social
A great start to #UTChrisWood25 - localized RCC discussions from diagnosis (ccRCC score) & novel tracers to treatment of surgery, SBRT, & ablation. #IvanPedrosa #ChadTang #JoseKaram #IsamuTachibana #mohamedabdelsalam & interactive panel discussion!
April 4, 2025 at 5:33 PM
Reposted by Tian Zhang, MD
oncodaily.bsky.social
Best practices for second line treatment in Metastatic Urothelial Carcinoma - @tiansterzhangmd.bsky.social .bsky.social

oncodaily.com/url/267046

#GUOnc #UrothelialCarcinoma #Cancer #OncoDaily #Oncology #GlobalAwareness #FightAgainstCancer
Tian Zhang: Best practices for second line treatment in Metastatic Urothelial Carcinoma - OncoDaily
Tian Zhang: Best practices for second line treatment in Metastatic Urothelial Carcinoma / Astellas, atezolizumab, Aveluma, Avelumab, Biomarker selection,
oncodaily.com
April 4, 2025 at 1:31 PM
tiansterzhangmd.bsky.social
@erplimackmd.bsky.social with killer discussion setting the scene for the #NIAGARA “sandwich” & #Checkmate274, both practice changing for our pts w #bladdercancer. @ascocancer.bsky.social #GU25
February 14, 2025 at 5:07 PM
tiansterzhangmd.bsky.social
#MattGalsky updating results of #NIAGARA - great to see pathologic complete responses from neoadj gem-cis-durvalumab — durva improves disease free & overall survival even in those w pathCR. @ascocancer.bsky.social #GU25
February 14, 2025 at 4:51 PM
tiansterzhangmd.bsky.social
#MattMilowsky with updated #Checkmate274 trial - adjuvant nivolumab after cystectomy improves time to recurrence & overall survival in #bladdercancer. Sets up ongoing #Alliance #MODERN trial! @ascocancer.bsky.social #GU25
February 14, 2025 at 4:44 PM
tiansterzhangmd.bsky.social
Mevrometostat with enzalutamide vs enza alone with nice PSA responses and good PFS benefit! @ascocancer.bsky.social #GU25
February 14, 2025 at 1:35 AM
tiansterzhangmd.bsky.social
#TanyaDorff w always thoughtful w discussion for metastatic #prostatecancer — buckets of treatments - doublets, triplets, XRT, including trials! #TRIPLESWITCH, #ADREAM, S1802, & more! @ascocancer.bsky.social #GU25
February 13, 2025 at 5:19 PM